z-logo
open-access-imgOpen Access
Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
Author(s) -
Nikolaos Alexandris,
George Lagoumintzis,
Christos T. Chasapis,
D.D. Leonidas,
Γεώργιος Παπαδόπουλος,
Socrates J. Tzartos,
Aristidis Tsatsakis,
Elias Eliopoulos,
Konstantinos Poulas,
Konstantinos Farsalinos
Publication year - 2020
Publication title -
toxicology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.013
H-Index - 37
ISSN - 2214-7500
DOI - 10.1016/j.toxrep.2020.12.013
Subject(s) - nicotinic agonist , cholinergic , repurposing , nicotinic acetylcholine receptor , acetylcholine receptor , acetylcholine , in silico , medicine , pharmacology , receptor , bioinformatics , neuroscience , biology , biochemistry , ecology , gene
Graphical abstract

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom